Investigation of mechanical recycling effect on electromagnetic properties of polylactic acid (PLA) – nanoclay nanocomposites: Towards a valorization of recycled PLA nanocomposites
Composites Part C: Open Access · 2023-03 · 10 · 100339
DOI: 10.1016/j.jcomc.2022.100339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Composites Part C: Open Access, 2023-03. Verfasst von Lakhdar Sidi Salah und 5 weiteren Autor:innen. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds De La Recherche Scientifique - FNRS, Ministerio de Economía y Competitividad, Horizon 2020.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Fonds De La Recherche Scientifique - FNRS
- Ministerio de Economía y Competitividad
- Horizon 2020
Zitieren
APA
Salah, L. S., Ouslimani, N., Danlée, Y., Beltrán, F. R., Huynen, I., & Orden, M. U. D. L. (2023). Investigation of mechanical recycling effect on electromagnetic properties of polylactic acid (PLA) – nanoclay nanocomposites: Towards a valorization of recycled PLA nanocomposites. Composites Part C: Open Access, 10, 100339. https://doi.org/10.1016/j.jcomc.2022.100339
Vancouver
Salah LS, Ouslimani N, Danlée Y, Beltrán FR, Huynen I, Orden MUDL. Investigation of mechanical recycling effect on electromagnetic properties of polylactic acid (PLA) – nanoclay nanocomposites: Towards a valorization of recycled PLA nanocomposites. Composites Part C: Open Access. 2023;10:100339. doi:10.1016/j.jcomc.2022.100339
BibTeX
@article{Salah2023,
author = {Salah, Lakhdar Sidi and Ouslimani, Nassira and Danlée, Yann and Beltrán, Freddys R. and Huynen, Isabelle and Orden, María Ulagares de la},
title = {Investigation of mechanical recycling effect on electromagnetic properties of polylactic acid (PLA) – nanoclay nanocomposites: Towards a valorization of recycled PLA nanocomposites},
journal = {Composites Part C: Open Access},
year = {2023},
volume = {10},
pages = {100339},
doi = {10.1016/j.jcomc.2022.100339}
}
EUVIMED